Published in Lancet on December 14, 2002
British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax (2003) 5.83
Systematic review and meta-analysis of strategies for the diagnosis of suspected pulmonary embolism. BMJ (2005) 1.44
CT imaging in acute pulmonary embolism: diagnostic strategies. Eur Radiol (2005) 1.42
CT venography vs ultrasound in the diagnosis of thromboembolic disease in patients with clinical suspicion of pulmonary embolism. Emerg Radiol (2007) 1.04
Reproducibility of multi-detector spiral computed tomography in detection of sub-segmental acute pulmonary embolism. Eur Radiol (2005) 0.94
The interobserver agreement between residents and experienced radiologists for detecting pulmonary embolism and DVT with using CT pulmonary angiography and indirect CT venography. Korean J Radiol (2008) 0.92
Diagnosis of pulmonary embolism with CT pulmonary angiography: a systematic review. Emerg Med J (2006) 0.92
Diagnosing pulmonary embolism. Postgrad Med J (2004) 0.88
Diagnosing pulmonary embolism: time to rewrite the textbooks. Int J Cardiovasc Imaging (2005) 0.88
Multislice computed tomography perfusion imaging for visualization of acute pulmonary embolism: animal experience. Eur Radiol (2005) 0.83
When to perform CTA in patients suspected of PE? Eur Radiol (2007) 0.82
Chinese multi-center study of lung scintigraphy and CT pulmonary angiography for the diagnosis of pulmonary embolism. Int J Cardiovasc Imaging (2012) 0.81
Computer-aided detection of pulmonary embolism at CT pulmonary angiography: can it improve performance of inexperienced readers? Eur Radiol (2011) 0.81
Ovarian vein thrombosis. Pan Afr Med J (2015) 0.81
Fusion imaging of computed tomographic pulmonary angiography and SPECT ventilation/perfusion scintigraphy: initial experience and potential benefit. Eur J Nucl Med Mol Imaging (2006) 0.80
Excluding pulmonary embolism with helical (spiral) computed tomography: Evidence is catching up with enthusiasm. CMAJ (2003) 0.79
Diagnostic yield of CT thorax angiography in patients suspected of pulmonary embolism: independent predictors and protocol adherence. Insights Imaging (2014) 0.78
Management of venous thromboembolism: an update. Thromb J (2016) 0.78
Evaluation of the usefulness of a D dimer test in combination with clinical pretest probability score in the prediction and exclusion of Venous Thromboembolism by medical residents. Thromb J (2014) 0.77
CT imaging of peripheral pulmonary vessel disease. Eur Radiol (2005) 0.76
A diagnostic strategy for pulmonary embolism based on standardised pretest probability and perfusion lung scanning: a management study. Eur J Nucl Med Mol Imaging (2003) 0.75
Lung scintigraphy in the diagnosis of pulmonary embolism: current methods and interpretation criteria in clinical practice. Radiol Oncol (2014) 0.75
Reduced z-axis coverage in multidetector-row CT pulmonary angiography decreases radiation dose and diagnostic accuracy of alternative diseases. Br J Radiol (2013) 0.75
Comparison of multidetector computed tomography findings with clinical and laboratory data in pulmonary thromboembolism. Pol J Radiol (2015) 0.75
Diagnostic implications of computed tomography pulmonary angiography in patients with pulmonary embolism. Ann Thorac Med (2016) 0.75
Economic evaluation of a clinical protocol for diagnosing emergency patients with suspected pulmonary embolism. Cost Eff Resour Alloc (2006) 0.75
Comparison of non-invasive diagnostic tests to multi-detector CT pulmonary angiography for the diagnosis of pulmonary embolism. J Cardiovasc Dis Res (2013) 0.75
Bayes pulmonary embolism assisted diagnosis: a new expert system for clinical use. Emerg Med J (2007) 0.75
Alternative diagnoses based on CT angiography of the chest in patients with suspected pulmonary thromboembolism. J Bras Pneumol (2016) 0.75
Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med (2005) 9.27
High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med (2005) 7.20
Treatment of pulmonary arterial hypertension. N Engl J Med (2004) 6.88
Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med (2006) 6.06
Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation (2010) 5.87
Macitentan and morbidity and mortality in pulmonary arterial hypertension. N Engl J Med (2013) 4.98
Multidetector-row computed tomography in suspected pulmonary embolism. N Engl J Med (2005) 4.80
Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol (2002) 4.79
Comparative diagnostic performances of auscultation, chest radiography, and lung ultrasonography in acute respiratory distress syndrome. Anesthesiology (2004) 4.49
Diagnosis of pulmonary embolism by multidetector CT alone or combined with venous ultrasonography of the leg: a randomised non-inferiority trial. Lancet (2008) 3.33
Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Circulation (2007) 3.17
Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation (2005) 2.98
Longitudinal monitoring of 2-long terminal repeat circles in peripheral blood mononuclear cells from patients with chronic HIV-1 infection. AIDS (2003) 2.98
Pulmonary arterial hypertension in patients treated by dasatinib. Circulation (2012) 2.87
Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scar-related ventricular tachycardia. Circulation (2012) 2.80
Validation of a model to predict adverse outcomes in patients with pulmonary embolism. Eur Heart J (2005) 2.66
Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest (2005) 2.64
Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study. Circulation (2013) 2.64
Chronic thromboembolic pulmonary hypertension. Circulation (2006) 2.58
Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study. Hepatology (2003) 2.57
Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output. JAMA (2012) 2.56
Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension. Am J Respir Crit Care Med (2012) 2.52
Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic review. Eur Heart J (2008) 2.51
Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med (2008) 2.48
New formula for predicting mean pulmonary artery pressure using systolic pulmonary artery pressure. Chest (2004) 2.47
Is pulmonary arterial hypertension really a late complication of systemic sclerosis? Chest (2009) 2.40
Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension. Eur Heart J (2006) 2.34
Vascular and right ventricular remodelling in chronic thromboembolic pulmonary hypertension. Eur Respir J (2012) 2.32
A computerized handheld decision-support system to improve pulmonary embolism diagnosis: a randomized trial. Ann Intern Med (2009) 2.27
Cardiovascular involvement, an overlooked feature of Erdheim-Chester disease: report of 6 new cases and a literature review. Medicine (Baltimore) (2004) 2.27
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension. N Engl J Med (2015) 2.23
Appropriateness of diagnostic management and outcomes of suspected pulmonary embolism. Ann Intern Med (2006) 2.17
CX(3)C chemokine fractalkine in pulmonary arterial hypertension. Am J Respir Crit Care Med (2002) 2.15
Mechanosensing in actin stress fibers revealed by a close correlation between force and protein localization. J Cell Sci (2009) 2.14
C-kit-positive cells accumulate in remodeled vessels of idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med (2011) 2.12
Graft ischemic time and outcome of lung transplantation: a multicenter analysis. Am J Respir Crit Care Med (2005) 2.08
Survival after bilateral versus single lung transplantation for patients with chronic obstructive pulmonary disease: a retrospective analysis of registry data. Lancet (2008) 2.03
Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era. Am J Respir Crit Care Med (2007) 2.03
Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1. Thromb Haemost (2010) 1.96
Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation (2011) 1.92
A totally thoracoscopic approach for pulmonary anatomic segmentectomies. Interact Cardiovasc Thorac Surg (2011) 1.90
Severe pulmonary hypertension during pregnancy: mode of delivery and anesthetic management of 15 consecutive cases. Anesthesiology (2005) 1.88
Ambrisentan therapy for pulmonary arterial hypertension. J Am Coll Cardiol (2005) 1.82
Does asbestos exposure cause airway obstruction, in the absence of confirmed asbestosis? Am J Respir Crit Care Med (2010) 1.81
Resection of pulmonary metastases from sarcoma: can some patients benefit from a less invasive approach? Ann Thorac Surg (2009) 1.78
In migrating cells, the Golgi complex and the position of the centrosome depend on geometrical constraints of the substratum. J Cell Sci (2008) 1.77
Development and validation of an immunoassay for identification of recent human immunodeficiency virus type 1 infections and its use on dried serum spots. J Clin Microbiol (2005) 1.77
Orbital shaker technology for the cultivation of mammalian cells in suspension. Biotechnol Bioeng (2005) 1.74
Defect of hepatocyte growth factor secretion by fibroblasts in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2003) 1.74
Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease. Chest (2004) 1.72
Integration of merged delayed-enhanced magnetic resonance imaging and multidetector computed tomography for the guidance of ventricular tachycardia ablation: a pilot study. J Cardiovasc Electrophysiol (2012) 1.72
Portopulmonary hypertension: survival and prognostic factors. Am J Respir Crit Care Med (2008) 1.71
Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a 1-year follow-up study. Chest (2003) 1.71
Primary graft failure following lung transplantation: predictive factors of mortality. Chest (2002) 1.70
Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J Am Coll Cardiol (2008) 1.69
Massive hemoptysis: what place for medical and surgical treatment. Eur J Cardiothorac Surg (2002) 1.69
Pulmonary Langerhans cell histiocytosis-associated pulmonary hypertension: clinical characteristics and impact of pulmonary arterial hypertension therapies. Chest (2012) 1.68
Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). Lung Cancer (2007) 1.68
Pulmonary fibrosis in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: a series of 49 patients and review of the literature. Medicine (Baltimore) (2014) 1.65
Derivation and validation of multimarker prognostication for normotensive patients with acute symptomatic pulmonary embolism. Am J Respir Crit Care Med (2014) 1.63
Selexipag for the Treatment of Pulmonary Arterial Hypertension. N Engl J Med (2015) 1.62
2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension. Rev Esp Cardiol (Engl Ed) (2016) 1.61
Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis. J Thorac Cardiovasc Surg (2003) 1.60
Survival benefit of lung transplant for cystic fibrosis since lung allocation score implementation. Am J Respir Crit Care Med (2013) 1.60
Erythropoietin and erythropoietin receptor coexpression is associated with poor survival in stage I non-small cell lung cancer. Clin Cancer Res (2007) 1.59
Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant (2007) 1.58
Lung retransplantation for bronchiolitis obliterans syndrome: long-term follow-up in a series of 15 recipients. Chest (2003) 1.58
Determinants of the survival benefit of lung transplantation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2008) 1.57
Single high-dose erythropoietin administration immediately after reperfusion in patients with ST-segment elevation myocardial infarction: results of the erythropoietin in myocardial infarction trial. Am Heart J (2012) 1.55
Potts shunt in children with idiopathic pulmonary arterial hypertension: long-term results. Ann Thorac Surg (2012) 1.54
IgG from patients with pulmonary arterial hypertension and/or systemic sclerosis binds to vascular smooth muscle cells and induces cell contraction. Ann Rheum Dis (2011) 1.53
Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French-Italian HHT network. Genet Med (2007) 1.52
Role of endothelium-derived CC chemokine ligand 2 in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med (2007) 1.52
Hui and Walter's latent-class reference-free approach may be more useful in assessing agreement than diagnostic performance. J Clin Epidemiol (2005) 1.51
Early prediction of in-hospital mortality of patients with hemoptysis: an approach to defining severe hemoptysis. Respiration (2011) 1.51
Pulmonary embolism during pregnancy: diagnosis with lung scintigraphy or CT angiography? Radiology (2010) 1.51
Magnetic resonance imaging criteria for distinguishing between inclusion body myositis and polymyositis. J Rheumatol (2002) 1.50
Factors influencing accuracy of CT-guided percutaneous biopsies of pulmonary lesions. Eur Radiol (2004) 1.50
Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation. Am J Respir Crit Care Med (2010) 1.50
A computed method for noninvasive MRI assessment of pulmonary arterial hypertension. J Appl Physiol (1985) (2003) 1.50
Calcium channel blocker reduces airway remodeling in severe asthma. A proof-of-concept study. Am J Respir Crit Care Med (2015) 1.48
Characterization of pulmonary arterial hypertension patients walking more than 450 m in 6 min at diagnosis. Chest (2010) 1.48
Computed tomographic measurement of airway remodeling and emphysema in advanced chronic obstructive pulmonary disease. Correlation with pulmonary hypertension. Am J Respir Crit Care Med (2015) 1.47
Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertension. Am J Respir Crit Care Med (2003) 1.46
Pleural plaques and the risk of pleural mesothelioma. J Natl Cancer Inst (2013) 1.46
Pre-implantation genetic diagnosis in pulmonary arterial hypertension due to BMPR2 mutation. Eur Respir J (2012) 1.45